PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
41.32%
Some net income increase while ORCL is negative at -47.63%. John Neff would see a short-term edge over the struggling competitor.
14.17%
D&A growth well above ORCL's 10.00%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
270.81%
Some yoy growth while ORCL is negative at -68.42%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
127.43%
SBC growth while ORCL is negative at -38.79%. John Neff would see competitor possibly controlling share issuance more tightly.
112.26%
Less working capital growth vs. ORCL's 804.81%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
377.55%
AR growth well above ORCL's 273.49%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
93.81%
Lower 'other working capital' growth vs. ORCL's 343.32%. David Dodd would see fewer unexpected short-term demands on cash.
-108.54%
Both negative yoy, with ORCL at -71.79%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
33.53%
Operating cash flow growth above 1.5x ORCL's 21.94%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
37.80%
CapEx growth well above ORCL's 36.03%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-732.72%
Negative yoy acquisition while ORCL stands at 79.89%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
15.46%
Some yoy expansion while ORCL is negative at -24.62%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
-4.81%
Both yoy lines are negative, with ORCL at -49.14%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
167.59%
Growth of 167.59% while ORCL is zero at 0.00%. Bruce Berkowitz sees a moderate difference requiring justification by ROI in these smaller invests.
-309.95%
We reduce yoy invests while ORCL stands at 60.76%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
111.50%
Stock issuance far above ORCL's 32.08%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
59.40%
Repurchase growth 1.25-1.5x ORCL's 47.21%. Bruce Berkowitz would confirm if the firm invests enough in expansions while boosting EPS.